SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $5,368,000 | +29.2% | 139,145 | +7.5% | 0.09% | +33.3% |
| Q3 2015 | $4,154,000 | -14.7% | 129,380 | -19.2% | 0.07% | 0.0% |
| Q2 2015 | $4,870,000 | +128.5% | 160,045 | -0.3% | 0.07% | +153.8% |
| Q1 2015 | $2,131,000 | -8.2% | 160,500 | 0.0% | 0.03% | -3.7% |
| Q4 2014 | $2,322,000 | -83.0% | 160,500 | -75.2% | 0.03% | -82.8% |
| Q3 2014 | $13,683,000 | -28.8% | 648,480 | +0.5% | 0.16% | -23.8% |
| Q2 2014 | $19,214,000 | +46.2% | 644,975 | +18.0% | 0.21% | +48.2% |
| Q1 2014 | $13,140,000 | +5.4% | 546,800 | -10.7% | 0.14% | +4.5% |
| Q4 2013 | $12,468,000 | -53.2% | 612,075 | +8.5% | 0.13% | -57.4% |
| Q3 2013 | $26,646,000 | +927.2% | 564,175 | +727.2% | 0.31% | +817.6% |
| Q2 2013 | $2,594,000 | – | 68,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |